tenk.fyi

Immunovant, Inc.

IMVTNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$505.6M

22.2% YoY

EPS

$-2.77

1.5% YoY

Cash

$902.1M

26.4% YoY

FY 2026 · As of 2026-03-31